Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 979-984, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masters, A. M.
Right arrow Articles by Hahnel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masters, A. M.
Right arrow Articles by Hahnel, R.

Clinical Chemistry, Vol 35, 979-984, Copyright © 1989 by American Association for Clinical Chemistry

Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol

AM Masters and R Hahnel
Endocrine Research Laboratories, King Edward Memorial Hospital for Women, Australia.

The aim of this study was to find reasons for the interference of sex- hormone binding globulin (SHBG) in direct radioimmunoassays (RIAs) for testosterone and estradiol. 125I-labeled testosterone and estradiol were compared with 3H-labeled testosterone and estradiol for their affinity to SHBG. The 3H-labeled steroids bound far more avidly to SHBG than did the corresponding 125I-labeled steroids. The SHBG concentration in the standard matrix of two kits was significant. Finally, 3H-labeled steroids were compared with 125I-labeled steroids for their affinity to the antibody supplied with the kits. The 125I- labeled steroids bound more avidly than did the 3H-labeled steroids to the corresponding antibodies. Direct testosterone and estradiol results would be influenced according to the SHBG in the sample, as observed.


The following articles in journals at HighWire Press have cited this article:


Home page
 Eur J EndocrinolHome page
C. Ankarberg-Lindgren and E. Norjavaara
A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17 -estradiol in prepubertal children
Eur. J. Endocrinol., January 1, 2008; 158(1): 117 - 124.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. S. Dighe and P. M. Sluss
Improved Detection of Serum Estradiol after Sample Extraction Procedure
Clin. Chem., April 1, 2004; 50(4): 764 - 766.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Taieb, B. Mathian, F. Millot, M.-C. Patricot, E. Mathieu, N. Queyrel, I. Lacroix, C. Somma-Delpero, and P. Boudou
Testosterone Measured by 10 Immunoassays and by Isotope-Dilution Gas Chromatography-Mass Spectrometry in Sera from 116 Men, Women, and Children
Clin. Chem., August 1, 2003; 49(8): 1381 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Rinaldi, H. Dechaud, C. Biessy, V. Morin-Raverot, P. Toniolo, A. Zeleniuch-Jacquotte, A. Akhmedkhanov, R. E. Shore, G. Secreto, A. Ciampi, et al.
Reliability and Validity of Commercially Available, Direct Radioimmunoassays for Measurement of Blood Androgens and Estrogens in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 757 - 765.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.